Medicare Enrolled

Dr. Kyle Scarborough, MD

Family Medicine · Conroe, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
603 S. CONROE MEDICAL CENTER BLVD, Conroe, TX 77304
9367609900
In practice since 2006 (19 years)
NPI: 1417045303 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Scarborough from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scarborough? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Scarborough

Dr. Kyle Scarborough is a family medicine in Conroe, TX, with 19 years in practice. Based on federal Medicare data, Dr. Scarborough performed 5,802 Medicare services across 3,381 unique beneficiaries.

Between the years covered by Open Payments, Dr. Scarborough received a total of $13,709 from 78 pharmaceutical and/or device companies across 895 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Scarborough is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $13,709 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,802
Medicare services
Top 3% in TX for family medicine
3,381
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~305 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,454$83$265
Office visit, established patient (20-29 min)867$51$182
Injection, methylprednisolone acetate, 20 mg633$4$11
Ceftriaxone antibiotic injection443$0$13
Annual wellness visit, follow-up436$124$283
Drug injection, under skin or into muscle414$9$66
Electrocardiogram (EKG), 12-lead340$7$42
Office visit, established patient, complex (40-54 min)242$123$354
Hemoglobin A1c test (diabetes monitoring)234$9$45
Urinalysis, manual190$3$8
Detection test by immunoassay with direct visual observation for influenza virus180$16$41
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus114$34$75
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)53$16$36
New patient office visit (45-59 min)43$106$285
New patient office visit (30-44 min)30$56$265
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment29$157$399
Removal of impacted ear wax by washing22$14$145
Injection, methylprednisolone acetate, 40 mg22$5$13
Transitional care management services for problem of high complexity16$210$561
Removal of impacted ear wax15$29$121
Destruction of precancerous skin growth, 113$41$160
Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report12$5$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,709
Total received (2018-2024)
Avg $1,958/year across 7 years
Top 3% in TX for family medicine
78
Companies
895
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,709 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,817
2023
$2,270
2022
$2,155
2021
$2,365
2020
$1,689
2019
$1,695
2018
$1,718

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,317
Lilly USA, LLC
$1,220
Takeda Pharmaceuticals U.S.A., Inc.
$1,068
Novo Nordisk Inc
$888
ABBVIE INC.
$859
AbbVie Inc.
$782
GlaxoSmithKline, LLC.
$612
PFIZER INC.
$547
Boehringer Ingelheim Pharmaceuticals, Inc.
$376
Amarin Pharma Inc.
$333
Janssen Pharmaceuticals, Inc
$312
Corium, LLC
$284
Paratek Pharmaceuticals, Inc.
$282
Allergan, Inc.
$277
Shire North American Group Inc
$277
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$238
Amgen Inc.
$202
Genentech USA, Inc.
$193
Dexcom, Inc.
$188
Otsuka America Pharmaceutical, Inc.
$183
Abbott Laboratories
$178
Horizon Therapeutics plc
$166
JAZZ PHARMACEUTICALS INC.
$164
Medtronic, Inc.
$160
Biohaven Pharmaceuticals, Inc.
$158
Merck Sharp & Dohme Corporation
$152
IDORSIA PHARMACEUTICALS US INC
$135
Endo Pharmaceuticals Inc.
$125
Axsome Therapeutics, Inc.
$115
Esperion Therapeutics, Inc.
$109
Exact Sciences Corporation
$107
Vertiflex, Inc.
$94
Currax Pharmaceuticals LLC
$92
Bayer HealthCare Pharmaceuticals Inc.
$83
SANOFI-AVENTIS U.S. LLC
$75
Tris Pharma Inc
$72
Lundbeck LLC
$65
Biohaven Pharmaceutical Holding Company Ltd.
$62
Nevro Corp.
$58
Astellas Pharma US Inc
$54
Eisai Inc.
$52
Tolmar, Inc.
$50
IBSA Pharma Inc.
$50
Teva Pharmaceuticals USA, Inc.
$48
Kowa Pharmaceuticals America, Inc.
$47
Hologic, LLC
$42
Ironwood Pharmaceuticals, Inc
$42
DEXCOM, INC.
$42
Medtronic Vascular, Inc.
$40
Prytime Medical Devices, Inc.
$39
Phadia US Inc.
$38
Acella Pharmaceuticals, LLC
$37
Ironshore Pharmaceuticals Inc.
$37
TherapeuticsMD, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
Antares Pharma, Inc.
$33
Merck Sharp & Dohme LLC
$33
Inspire Medical Systems, Inc.
$25
Cumberland Pharmaceuticals, Inc.
$22
Azurity Pharmaceuticals, Inc.
$21
AbbVie, Inc.
$20
Melinta Therapeutics, Inc.
$19
Ardelyx, Inc.
$19
PhotoniCare Inc
$18
Alnylam Pharmaceuticals Inc.
$18
Sumitomo Pharma America, Inc.
$18
Neos Therapeutics, LP
$16
Nalpropion Pharmaceuticals LLC
$16
Allergan Inc.
$15
Purdue Pharma L.P.
$15
EISAI INC.
$14
Horizon Pharma plc
$14
Evofem Biosciences, Inc.
$14
Optos, Inc.
$14
Philips North America LLC
$13
Ultragenyx Pharmaceutical Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 26.3% of total payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · AJOVY · AZSTARYS · Adzenys XR-ODT · Aimovig · Amitiza · Aptima HPV · Auvelity · Azstarys · BELSOMRA · BEVESPI AEROSPHERE · BOTOX · BREZTRI · BREZTRI AEROSPHERE · Baxdela · Belviq · CHANTIX · COMIRNATY · CONTRAVE · COPAXONE · COREVALVE EVOLUT R · ClosureFast · Cologuard Collection Kit · Cryvista · DEXCOM G6 TRANSMITTER · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · ER-REBOA · ETERNA · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · IBSRELA · IMVEXXY · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · Kristalose 20gm · LIVALO · LYRICA · Linzess · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · NASCOBAL · NEXLETOL · NP Thyroid 60 · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · OCT OPHTHALMOSCOPE · ONZETRA XSAIL · OXLUMO · Orilissa · Otezla · OtoSight Middle Ear Scope · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Phexxi · Prolia · QULIPTA · QUVIVIQ · RAYOS · REXULTI · REYVOW · RYBELSUS · Repatha · Resolute · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · Saxenda · Senza · Superion ISS · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tirosint · Tresiba · Trintellix · UBRELVY · VECTRIS SURESCAN · VENASEAL · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in TX.

Equivalent to $236 per 100 Medicare services performed
Looking for a family medicine in Conroe?
Compare family medicines in the Conroe area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
445
Per 100K population
68.0
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Scarborough is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Scarborough experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Scarborough performed 1,454 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Scarborough receive payments from pharmaceutical companies?
Yes. Dr. Scarborough received a total of $13,709 from 78 companies across 895 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scarborough's costs compare to other family medicines in Conroe?
Dr. Scarborough's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scarborough) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →